Sterling Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
12,580
-413
-3% -$50K 0.02% 457
2026
Q1
$2.12M Buy
12,993
+10,811
+495% +$1.66M 0.04% 322
2025
Q4
$380K Buy
2,182
+1,195
+121% +$218K 0.01% 1071
2025
Q3
$142K Sell
987
-12
-1% -$1.47K ﹤0.01% 1419
2025
Q2
$101K Buy
999
+818
+452% +$62.5K ﹤0.01% 1357
2025
Q1
$13.8K Buy
181
+4
+2% +$306 ﹤0.01% 1769
2024
Q4
$12.2K Buy
177
+18
+11% +$1.3K ﹤0.01% 2073
2024
Q3
$11.6K Buy
+159
New +$11.7K ﹤0.01% 1537

Other funds holding INSM

Sterling Capital Management's INSM Position: Q2 2026 in Review

Sterling Capital Management reduced its Insmed (INSM) stake by 3.2% in Q2 2026, selling an estimated $50K and leaving 12,580 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #457.

Sterling Capital Management first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.12M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Sterling Capital Management held 12,580 shares of Insmed worth $1.34M as of Q2 2026.
  • Sterling Capital Management sold 413 Insmed shares in Q2 2026, an estimated $50K.
  • Insmed made up 0.02% of Sterling Capital Management's portfolio in Q2 2026, its #457 holding.
  • Sterling Capital Management first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Insmed position peaked at $2.12M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.